Asiri Surgical Hospital PLC 2024 AR2
The report highlights Asiri Surgical Hospital PLC's operational and financial performance for the fiscal year 2023/24, showcasing a 17% revenue growth to LKR 6.62 billion. Key achievements include performing the nation's first Transcatheter Aortic Valve Implantation (TAVI) heart procedure and launching a dedicated Lifestyle Medicine Unit. The company also advanced its clinical capabilities in oncology, liver transplants, and nephrology. On the sustainability front, the hospital maintained its ACHS accreditation, achieved a low Lost Time Injury Frequency Rate of 1.4, and committed to reducing greenhouse gas emissions and electricity usage by 10% by 2030.
Company: Asiri Surgical Hospital PLC
Sector: Healthcare & social services
Country: Sri Lanka
Year: 2024
Type: AR2
Pages: 128
Back to company
Asiri Surgical Hospital PLC
Annual Report
The report highlights Asiri Surgical Hospital PLC's operational and financial performance for the fiscal year 2023/24, showcasing a 17% revenue growth to LKR 6.62 billion. Key achievements include performing the nation's first Transcatheter Aortic Valve Implantation (TAVI) heart procedure and launching a dedicated Lifestyle Medicine Unit. The company also advanced its clinical capabilities in oncology, liver transplants, and nephrology. On the sustainability front, the hospital maintained its ACHS accreditation, achieved a low Lost Time Injury Frequency Rate of 1.4, and committed to reducing greenhouse gas emissions and electricity usage by 10% by 2030.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2: